14 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
12213077	18	Inhibition of the antibacterial target UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC): isoxazoline zinc amidase inhibitors bearing diverse metal binding groups.	Duke University
10091675	31	Carbohydroxamido-oxazolidines: antibacterial agents that target lipid A biosynthesis.	Merck Research Laboratories
28302397	73	Structure-based discovery of LpxC inhibitors.	Cubist Pharmaceuticals
28082037	18	Sulfonamide-based non-alkyne LpxC inhibitors as Gram-negative antibacterial agents.	Kyorin Pharmaceutical
27326338	15	LpxC Inhibitors: Design, Synthesis, and Biological Evaluation of Oxazolidinones as Gram-negative Antibacterial Agents.	Kyorin Pharmaceutical
24412340	24	Synthesis, biological evaluation and molecular docking studies of benzyloxyacetohydroxamic acids as LpxC inhibitors.	Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
23914798	4	Synthesis, structure, and antibiotic activity of aryl-substituted LpxC inhibitors.	Duke University
23499237	25	Exploring the UDP pocket of LpxC through amino acid analogs.	Astrazeneca
22401863	30	Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC.	Pfizer
21273067	46	Design and synthesis of potent Gram-negative specific LpxC inhibitors.	Merck Research Laboratories
21194954	4	Syntheses, structures and antibiotic activities of LpxC inhibitors based on the diacetylene scaffold.	Jilin University
18025458	10	Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand binding.	Duke University Medical Center